These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3838478)

  • 1. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves' disease patients.
    Szabó J; Leövey A; Karányi Z; Várvölgyi C; Fórizs E; Herceg L
    Acta Med Hung; 1989; 46(1):23-30. PubMed ID: 2570399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of possible antiidiotypic control mechanisms in Graves' disease.
    Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
    J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P; Adler G; Roulier R; Lissitzky S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.
    Balázs C; Molnár I
    Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodies.
    Hensen J; Kotulla P; Finke R; Bogner U; Badenhoop K; Meinhold H; Schleusener H
    J Clin Endocrinol Metab; 1984 Jun; 58(6):980-7. PubMed ID: 6144692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
    Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
    J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH binding by globulins from patients with Graves' disease.
    Bíró J
    Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a radioreceptor assay for TSH-binding inhibiting immunoglobulins (TBII).
    Heberling HJ; Bierwolf B; Lohmann D
    Exp Clin Endocrinol; 1988 Aug; 91(3):355-61. PubMed ID: 2908034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of TSH-binding inhibiting immunoglobulins in patients with Graves' disease and non toxic goiter.
    Mossetti G; Salomone Megna A; Lanzano C; Maddaloni D; Leonello D; Gravina E
    Boll Ist Sieroter Milan; 1986; 65(4):277-82. PubMed ID: 2878674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.